Dr. Robert Califf, a cardiologist who has spent most of his career at Duke University, was confirmed by the Senate on February 24, 2016, to be the next FDA commissioner, following President Barack Obama’s nomination in September 2015.
Posts Tagged ‘translational research’
Why And How Are Companies Investing In Precision Medicine
HIT Consultant, a digital publication focused on healthcare technology, recently shared a report by Reed Smith on mergers and acquisitions (M&A) in life sciences and how personalized medicine is playing an important role in many of today’s transactions. While pharmaceutical and biotechnology companies have not abandoned the “one-size-fits all” approach to developing drugs, many […]
3 Recommendations For Moving Precision Medicine Forward
Since President Obama’s State of the Union address in January, much has been said about precision medicine. And, rightly so. The ability to treat common and rare diseases based on genomic and patient data is showing incredible promise. However, the medical community agrees that significant changes need to be made to federal healthcare policies […]
Living In A Personalized World: Drug Dosing And Safety
Dr. Janet Woodcock, the director of the Center for Drug Evaluation and Research (CDER) at the FDA, recently posted a blog piece that discussed the department’s strides in precision and personalized medicine. She points out that since 2012, CDER has approved 30 targeted therapies, eight of which were in 2014.
Top 5 Life Sciences Blog Posts From March 2015
Now that April is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in March – they’re ranked in order of popularity, with number one being the most viewed piece.
Launched with a $215 million investment in the President Obama’s 2016 Budget, the Precision Medicine Initiative will pioneer a new model of patient-powered research that promises to accelerate biomedical discoveries and provide clinicians with new tools, knowledge, and therapies to select the treatments that will work best for their patients.
Making The 0.1% Count
Obama’s $215 million precision medicine plan. UCSF’s hire of big data expert Dr. Atul Butte. It’s safe to say that data warehousing and analytics is hot among the life sciences and healthcare communities and there’s really no end in sight. Academic medical centers (AMCs), hospitals, and drug makers all over the world are already […]
Disease-Independent Enterprise Data Warehouse
Much of the industry efforts to date for personalized medicine have been disease specific and myopic in nature. While I believe this was necessary to evolve and mature, some organizations are taking a broader view of their data using advanced analytics to identify patient populations for targeted therapies that take into account an individual […]
Personalized Medicine In A Nutshell (Or Shall I Say Capsule?)
I recently heard a segment on the radio about personalized medicine. Or “translational medicine.” Or “translational research.” Or “precision medicine.” Whatever you want to call it! Dr. Murray Feingold, a pediatrician and geneticist in the Boston area, painted a clear description of the term. He put it in words that all of us can understand. […]